Brief: Adial Advances To Second Cohort In Pharmacokinetics Study Of Ad04
23/07/2024 13:32
July 23 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ADVANCES TO SECOND COHORT IN
PHARMACOKINETICS STUDY OF AD04 FOR THE TREATMENT OF ALCOHOL USE
DISORDER
* ADIAL PHARMACEUTICALS INC: TOPLINE RESULTS FROM BOTH
COHORTS ARE
EXPECTED TO BE ANNOUNCED DURING Q4
Source text for Eikon: ID:nGNX6JbcWc
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)